Peter Schuld
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Rheumatology top 10%
- Eosinophilic Disorders and Syndromes
Papers in
- Hematology 20
- Chronic Myeloid Leukemia Treatments 19
- Acute Myeloid Leukemia Research 1
-
- Intramuscular injections and effects 1
- Co-authors
- François‐Xavier Mahon (5 shared papers)Mathiéu Molimard (3 shared papers)Stéphane Bouchet (2 shared papers)R. Lassalle (1 shared paper)Karine Titier (1 shared paper)Coralie Bélanger (1 shared paper)Nicholas D Moore (1 shared paper)Nicolas Widmer (1 shared paper)
- Journals
- Blood (6 papers)Leukemia (4 papers)HemaSphere (3 papers)Haematologica (2 papers)Leukemia Research (1 paper)
- Partner nations
- GermanySwitzerlandFrance
In The Last Decade
Peter Schuld
18 papers receiving 458 citations
Peers
Comparison fields: 5 of 44
- Hematology 276
- Rheumatology 78
- Pharmacology 54
- Pharmaceutical Science 18
- Pediatrics, Perinatology and Child Health 31
Countries citing papers authored by Peter Schuld
This map shows the geographic impact of Peter Schuld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schuld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schuld more than expected).
Fields of papers citing papers by Peter Schuld
This network shows the impact of papers produced by Peter Schuld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schuld. The network helps show where Peter Schuld may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Schuld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 131 | |
| 2 | 2015 | 95 | |
| 3 | 2012 | 63 | |
| 4 | 2007 | 49 | |
| 5 | 2014 | 46 | |
| 6 | 2003 | 37 | |
| 7 | 2011 | 9 | |
| 8 | 2012 | 9 | |
| 9 | 2019 | 9 | |
| 10 | 2020 | 8 | |
| 11 | 2011 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2013 | 3 | |
| 14 | 2005 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2010 | 0 | |
| 20 | 2026 | 0 |
About Peter Schuld
Peter Schuld is a scholar working on Hematology, Emergency Medicine, Genetics, Rheumatology and Endocrinology, Diabetes and Metabolism, having authored 21 papers that have together received 473 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (19 papers), Intramuscular injections and effects (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Eosinophilic Disorders and Syndromes (1 paper), Acute Myeloid Leukemia Research (1 paper), Growth Hormone and Insulin-like Growth Factors (1 paper), Patient-Provider Communication in Healthcare (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Hematology (276 citations), Rheumatology (78 citations), Pharmacology (54 citations), Pharmaceutical Science (18 citations) and Pediatrics, Perinatology and Child Health (31 citations). Peter Schuld has collaborated with scholars based in Germany, Switzerland and France. Frequent co-authors include François‐Xavier Mahon, Mathiéu Molimard, Stéphane Bouchet, R. Lassalle, Karine Titier, Coralie Bélanger, Nicholas D Moore, Nicolas Widmer, Laurent Arthur Decosterd and Thierry Buclin. Their work appears in journals such as Blood, Leukemia, HemaSphere, Haematologica and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.